An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

A study comparing the use of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects with Rheumatoid Arthritis.

Phase 2

Samsung Bioepis Co., Ltd.

Adalimumab